Deutsche Bank Ag\ Inhibrx, Inc. Transaction History

Deutsche Bank Ag\

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.76 - $39.56 $1.26 Million - $1.52 Million	38,496 Added 236.06%	54,804 $1.92 Million
Q4 2023 Feb 14, 2024	BUY	$14.5 - $38.0 $1,218 - $3,192	84 Added 0.52%	16,308 $619,000
Q3 2023 Nov 09, 2023	BUY	$15.75 - $26.31 $33,957 - $56,724	2,156 Added 15.33%	16,224 $297,000
Q2 2023 Aug 14, 2023	SELL	$16.96 - $27.82 $165,784 - $271,940	-9,775 Reduced 41.0%	14,068 $365,000
Q1 2023 May 15, 2023	BUY	$18.45 - $27.14 $110,072 - $161,917	5,966 Added 33.37%	23,843 $449,000
Q4 2022 Feb 13, 2023	BUY	$20.18 - $33.33 $80,518 - $132,986	3,990 Added 28.73%	17,877 $440,000
Q3 2022 Nov 14, 2022	SELL	$11.58 - $24.73 $7,538 - $16,099	-651 Reduced 4.48%	13,887 $250,000
Q2 2022 Aug 11, 2022	SELL	$8.52 - $25.26 $471,011 - $1.4 Million	-55,283 Reduced 79.18%	14,538 $165,000
Q1 2022 May 13, 2022	SELL	$19.89 - $43.18 $70,171 - $152,339	-3,528 Reduced 4.81%	69,821 $1.56 Million
Q4 2021 Feb 11, 2022	BUY	$26.75 - $46.02 $74,070 - $127,429	2,769 Added 3.92%	73,349 $3.2 Million
Q3 2021 Nov 04, 2021	SELL	$25.18 - $37.81 $13,093 - $19,661	-520 Reduced 0.73%	70,580 $2.35 Million
Q2 2021 Aug 11, 2021	BUY	$14.69 - $27.52 $964,545 - $1.81 Million	65,660 Added 1206.99%	71,100 $1.96 Million
Q1 2021 May 13, 2021	SELL	$16.27 - $41.26 $4,246 - $10,768	-261 Reduced 4.58%	5,440 $109,000
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $90,987 - $285,050	5,701 New	5,701 $188,000

18.6K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $550M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.